Mark Plavsic insider trades: Aura Biosciences (AURA) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Mark reports to the SEC
Open-market buys and sales
6 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 17, 2026 | AURA | ↓ Sell | 15,890 | $5.05 | $80K | Direct | Feb 17, 2026 (0d) |
| Oct 16, 2025 | AURA | ↓ Sell | 12,169 | $6.35 | $77K | Direct | Oct 16, 2025 (0d) |
| Feb 18, 2025 | AURA | ↓ Sell | 2,151 | $7.75 | $17K | Direct | Feb 18, 2025 (0d) |
| Oct 16, 2024 | AURA | ↓ Sell | 7,383 | $9.85 | $73K | Direct | Oct 16, 2024 (0d) |
| Jan 10, 2023 | FATE | ↓ Sell | 3,418 | $5.24 | $18K | Direct | Jan 11, 2023 (1d) |
| Jul 5, 2022 | FATE | ↓ Sell | 3,719 | $24.61 | $92K | Direct | Jul 6, 2022 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other AURA insiders
Open-market trades in the last 12 months
About Mark Plavsic's insider trades
Mark Plavsic is Chief Technology Officer at Aura Biosciences (AURA). Since Jul 5, 2022, Mark has reported no open-market purchases and 6 sales worth $356K on SEC Form 4. In the last 12 months: 1 sale ($80K).
Their filings also include grants and awards (5 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every AURA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.